Westside Investment Management »

Crispr Therapeutics shares owned by Westside Investment Management

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Westside Investment Management from 13F filings

Historical chart of Westside Investment Management investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Westside Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Westside Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $303k 6.4k 46.98
2024-06-30 $403k 7.5k 54.01
2024-03-31 $504k 7.4k 68.16
2023-12-31 $442k 7.1k 62.60
2023-09-30 $318k 7.0k 45.39
2023-06-30 $394k 7.0k 56.14
2023-03-31 $323k 7.1k 45.23
2022-12-31 $314k 7.7k 40.59
2022-09-30 $505k 7.7k 65.35
2022-06-30 $469k 7.7k 60.68
2022-03-31 $497k 7.9k 62.72
2021-12-31 $580k 7.7k 75.65
2021-09-30 $420k 3.8k 111.90
2021-06-30 $471k 2.9k 161.80
2021-03-31 $342k 2.8k 121.79
2020-12-31 $45k 300 150.00
2020-09-30 $32k 400 80.00
2020-06-30 $43k 612 70.51
2020-03-31 $36k 862 41.98
2019-06-30 $4.0k 100 40.00
2018-12-31 $2.9k 100 28.57
2018-09-30 $4.2k 100 42.34
2018-06-30 $6.0k 100 60.05
2017-12-31 $2.6k 100 26.07
2017-09-30 $2.0k 100 19.70
2017-06-30 $1.6k 100 16.03
2017-03-31 $2.0k 100 19.85